NeurologyLive Top Expert Interviews: August 2021


Expert clinicians offer their perspectives on the upcoming IFN 2021 Congress, the impact of aducanumab, optic neuritis in NMOSD, cranial neuralgias, and miniature AD brain models.

The NeurologyLive team has been as busy as always bringing you the latest clinical news and research updates in neurology over the last month, including conducting several interviews with experts across a number of different and varying topics.

Among these included a preview of the upcoming and third annual International Congress on the Future of Neurology (IFN) with migraine section head Jessica Ailani, MD; perspective on a miniature brain model’s potential in Alzheimer disease from Yanhong Shi, PhD;1 insight on the controversial approval of aducanumab from Eric Reiman, MD; the personalization of treatment for cranial neuralgias detailed by Paul G. Mathew, MD, DNBPAS, FAAN, FAHS;2 and Melanie Truong-Le, DO, OD, on the diagnosis of optic neuritis and NMOSD.

Click through the slides to see and read more from each expert’s exclusive conversation with NeurologyLive in August 2021.

To hear more insight from experts in the clinical care of patients and leading researchers in neurology, check out more of NeurologyLive's videos.

1. City of Hope researchers develop miniature brain models to study the causes of Alzheimer’s disease and to test drugs in development. News release. City of Hope. August 2, 2021.
2. Demos G, Foff EP, McEvoy B, Skoog B. Pimavanserin and concomitant antidementia medication use in patients with neurodegenerative and/or neurovascular disorders: safety outcomes from pooled clinical data and the HARMONY study. Presented at: AAIC 2021; Denver, Colorado; July 26-30. Poster 57661.
Recent Videos
Clifford R. Jack Jr., MD
David T. Jones, MD
Clifford R. Jack Jr., MD
 Lisa Mosconi, PhD
 Justin Davanzo, MD
1 KOL is featured in this series.
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
5 KOLs are featured in this series.
5 KOLs are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.